# FDA 483 - Hubei JXBio Pharmaceutical Co., Ltd - August 30, 2024

Source: https://www.globalkeysolutions.net/records/483/hubei-jxbio-pharmaceutical-co-ltd/9eff666e-9662-4a10-aa64-6820f3666c60

> FDA 483 for Hubei JXBio Pharmaceutical Co., Ltd on August 30, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hubei JXBio Pharmaceutical Co., Ltd
- Inspection Date: 2024-08-30
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2025-03-10](https://www.globalkeysolutions.net/records/483/hubei-jxbio-pharmaceutical-co-ltd/260c2286-bf63-4d04-b161-ab8a6a345549)
- [483 - 2025-03-14](https://www.globalkeysolutions.net/records/483/hubei-jxbio-pharmaceutical-co-ltd/8fe0c5e4-dc21-4ad0-89ce-0b9aec996457)
- [483 - 2025-03-14](https://www.globalkeysolutions.net/records/483/hubei-jxbio-pharmaceutical-co-ltd/5728e00e-8bc9-4018-8315-245d405f1eed)

## Related Officers

- [Saed Asbyl](https://www.globalkeysolutions.net/people/saed-asbyl/c0a03e9f-7dc5-4ca0-84f7-5cd1630fd616)

Company: https://www.globalkeysolutions.net/companies/hubei-jxbio-pharmaceutical-co-ltd/0cb70a5f-908f-45e1-bf50-87d4e83281b5

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1